Regional reporting of adverse drug reactions:: A new computer-based network

被引:0
|
作者
Swoboda, WJ [1 ]
Göttler, M
Hasford, J
机构
[1] Univ Munich, Dept Neurol, D-80539 Munich, Germany
[2] Univ Munich, Dept Med Informat Biometry & Epidemiol, Pharmacoepidemiol Res Grp, Munich, Germany
关键词
adverse drug reaction (ADR); adverse event (AE); reporting; network; EUROSCAPE; EDIFACT; ICH; data security; digital signature;
D O I
10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of drugs is always accompanied by the risk of adverse drug reactions (ADRs) and adverse events (AE). Generally physicians, pharmaceutical manufacturers, and pharmacists use a paper-based form for sending spontaneous ADR and AE reports to the national drug regulatory authority. Besides under-reporting, reporting lag-time and errors through data transformation are a major issue. In order to improve the current reporting situation we have set up a new computer-based, network-driven system for storing, transferring, and evaluating ADR reports. The system consists of three regional centres, one coordinating centre, and the central ADR database of the national drug regulatory authority. In the regional centres, clinical pharmacologists collect ADR data in local databases. There is a comfortable user-interface with an online help-function available. New reports are sent automatically to the Federal Agency using EUROSCAPE as a standardized electronic report form of the EU. The coordinating centre in Munich is responsible for overall performance and quality assurance. This model for a clinical health information network is of a high level of data security, is reliable and easily expandable through the use of standard tools, is fast and also inexpensive by using standard shareware products. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:S47 / S53
页数:7
相关论文
共 50 条
  • [21] Pharmacovigilance and Reporting Adverse Drug Reactions
    Isa, N. M.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2014, 9 (02): : 92 - 102
  • [22] Reporting of adverse drug reactions - Response
    不详
    POSTGRADUATE MEDICINE, 1997, 102 (01) : 36 - 36
  • [23] Reporting of adverse drug reactions in children
    Seyberth, H. W.
    MONATSSCHRIFT KINDERHEILKUNDE, 2008, 156 (01) : 63 - 64
  • [24] Pharmacovigilance and the reporting of adverse drug reactions
    Terblanche, Antoinette
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (06) : 65 - 68
  • [25] REPORTING ADVERSE DRUG-REACTIONS
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1985, 68 (10): : 703 - 703
  • [26] Adverse Drug Reactions: Investigating to Reporting
    Osborne, Carol-Anne
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 19 (01) : 46 - 47
  • [27] Mandatory Reporting of Adverse Drug Reactions
    Vaillancourt, Regis
    Gervais, Alan
    Gauthier, Claire
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 : 45 - 46
  • [28] Advances in computer-based assessment & reporting
    Kurz, Rainer H.
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2024, 59 : 524 - 525
  • [29] COMPUTER-BASED TERMINAL FOR RADIOLOGICAL REPORTING
    BROLIN, I
    INTERNATIONAL JOURNAL OF MAN-MACHINE STUDIES, 1969, 1 (02): : 211 - +
  • [30] Adverse drug reactions reporting: Pharmacovigilance knowledge of general public in a regional university hospital
    Bres, V.
    Deshormiere, N.
    Philibert, C.
    Lebrun, J.
    Perosa, C.
    Nouailles, M. Teulon
    Robin, V.
    Pinzani, V.
    Hillaire-Buys, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 61 - 61